Filing Details
- Accession Number:
- 0001209191-23-033041
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-30 20:02:28
- Reporting Period:
- 2023-05-25
- Accepted Time:
- 2023-05-30 20:02:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1750019 | Tcr2 Therapeutics Inc. | TCRR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1178579 | C Kevin Tang | 4747 Executive Drive, Suite 210 San Diego CA 92121 | No | No | Yes | No | |
| 1191935 | Tang Capital Partners Lp | 4747 Executive Drive Suite 210 San Diego CA 92121 | No | No | Yes | No | |
| 1232621 | Tang Capital Management Llc | 4747 Executive Drive Suite 210 San Diego CA 92121 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-05-25 | 50,000 | $1.72 | 4,394,800 | No | 4 | P | Indirect | By LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By LP |
Footnotes
- The prices reported in Column 4 are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $1.65 to $1.77. The Reporting Persons undertake to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnote 1 herein.
- The shares are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin Tang is the sole manager of Tang Capital Management, LLC ("TCM"), which is the general partner of TCP. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP.
Billionaire Hedge Funds
